Handmade quality · Free shipping over $75 · Explore the atelier

PI-1840 - CAS# 1401223-22-0 ogest GGTI-298 disrupts MAP kinase activation

SKU: 26486468073

4.8
USD90.00 USD129.00

Pay in 4 interest-free payments of $22.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells

2004 Aug 31

7-dihydroxy-chroman-4-one

and delay in tumor recurrence

PI-1840 - CAS# 1401223-22-0 ogest GGTI-298 disrupts MAP kinase activationPI 1840 is a is a novel rapidly reversible proteasome inhibitor with antitumor activity. It shows selective inhibitor for chymotrypsin like (CT L) over trypsin like and peptidylglutamyl peptide hydrolyzing activities of the proteasome. Product information CAS Number: 1401223 22 0 Molecular Weight: 394. 47 Formula: C22H26N4O3 Chemical Name: N (propan 2 yl) 2 (4 propylphenoxy) N {[3 (pyridin 3 yl) 1,2,4 oxadiazol 5 yl]methyl}acetamide Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products